Mmetụta na ọrụ nke paclitaxel

Paclitaxel sitere na Taxus chinensis ma bụrụ ihe mbụ achọtara nwere mmetụta mgbochi na mkpụrụ ndụ etuto.Ọdịdị nke paclitaxel dị mgbagwoju anya, a na-egosipụtakwa ngwa ahụike ya na ọgwụgwọ ọrịa cancer ara, ọrịa cancer akpa ume, na ọrịa cancer ovarian.Paclitaxelbụ metabolite nke abụọ ewepụtara site n'ụgbụgbọ Taxus chinensis nke ndị American chemists, nke nwere mmetụta mgbochi tumor dị mma.Ka anyị leba anya na arụmọrụ na ọrụ paclitaxel.

Mmetụta na ọrụ nke paclitaxel

The nrụpụta na ọrụ nkepaclitaxel

1. Mmetụta mgbochi tumor

Paclitaxel bụ ọgwụ na-egbochi microtubule antitumor.Paclitaxel nwere ike ịkwalite mgbakọ microtubule site n'ịkwalite polymerization nke spinosomal tubulin subunits, ọbụna na ndị ogbugbo chọrọ maka mgbakọ microtubule nkịtị (dị ka GTP, guanosine triphosphate, wdg)., wdg) nwekwara ike inwe mmetụta a, na-eme ka e guzobe microtubules na-adịghị arụ ọrụ, kwụsiri ike.

2. Mgbochi ọrịa cancer

Paclitaxel nwere mmetụta anticancer na ahịrị mkpụrụ ndụ sarcoma dị njọ, leukemia na melanoma dị njọ.Paclitaxel bụkwa ọgwụ izizi maka ụmụ nwanyị nwere oke ara na ọrịa ovarian.Paclitaxel nwere ike jikọta na microtubules, nke nwere ike "ifiri" ma gbochie nkewa nke chromosomes n'oge nkewa sel, nke nwere ike igbu mkpụrụ ndụ kansa ngwa ngwa.

3. Ọgwụgwọ ọrịa ogbu na nkwonkwo

Nnyocha egosiwo na paclitaxel ka FDA kwadoro maka ọgwụgwọ ọrịa ogbu na nkwonkwo, na paclitaxel gel bụ usoro nhazi nke ọgwụ.paclitaxel maka ọgwụgwọ rheumatoid ogbu na nkwonkwo.

Cheta na: Enwere ike ịrụ ọrụ na ngwa a kọwara n'isiokwu a site na akwụkwọ ndị e bipụtara.

paclitaxel API

Ọgụgụ agbatịkwuru:Yunnan Hande Biotechnology Co., Ltd nọ na-elekwasị anya na mmepụta nke paclitaxel kemgbe afọ 28.Ọ bụ ụlọ ọrụ izizi nọọrọ onwe ya n'ụwa nke paclitaxel ọgwụ anticancer sitere na osisi nke US FDA, European EDQM, Australian TGA, China CFDA, India, Japan na ụlọ ọrụ nchịkwa mba ndị ọzọ kwadoro.ụlọ ọrụ.Ọ bụrụ na ị chọrọ ịzụPaclitaxel API,biko kpọtụrụ anyị online.


Oge nzipu: Sep-30-2022